NEWS
IN THE NEWS
Testing for a Safer Future
the import of GM crops that have passed (91/414). Little consideration appears
SafePharm Laboratories, an independent privately scientific evaluation. to have been given to the impact of
owned contract research company has over 25
Directive 91/414, the ECPA says.
years experience of providing testing and
registration services to the chemical industry. A full
n Germany has witnessed the
range of testing is available, including:
destruction of numerous field trials on NORTH AMERICA
genetically-modified crops, the Federal
Physico-chemical Properties
Ministry of Agriculture and Consumer n The area planted with genetically-
Ecotoxicology
Protection (BMELV) reports. Given the modified maize in the US this year has
Mammalian Toxicology
country’s recent tightening of GM crop increased by 42% to about 67.8 million
rules, which increase data requirements acres (27.4 million ha), according to the
Genotoxicology
for approvals, the damage could impact latest estimates from the USDA. Some
In Vitro Alternative Toxicology
on companies’ ability to register 73% of the 92.9 million-acre crop has
GM crops in the country, the BMELV been planted with GM lines, compared
Regulag tory Affairs indicates. with 61% of the 78.3 million acres grown
last year.
n French agrochemical sales in 2006
amounted to €1,721 million ($2,305 n The USDA’s Animal and Plant Health
million), down by 8% over 2005, and Inspection Service (APHIS) has issued a
For further information please contact:act:
representing a 20% drop compared draft environmental impact statement
Marketing Dept
SafePharm Laboratories Ltd with 1999. The French agrochemical on potential revisions to the regulation
Shardlow Business Park,
industry association, the UIPP, attributes of genetically-modified crops and other
Shardlow, Derby, DE72 2GD, UK
Tel: +44 (0)1332 792896 the decline to: structural changes, organisms. The proposed changes
Fax:+44 (0)1332 799018
such as economic and agricultural include broadening the scope of APHIS
Email:
marketing@safepharm.co.uk
Web:
safepharm.co.uk developments; regulatory pressures; regulations and providing exemptions
and unfavourable climatic or pest for certain low-risk organisms.
conditions.
n The US EPA is to present its latest
n The European Court of the First analysis of the risks of the herbicide,
Instance has annulled the inclusion of atrazine, to amphibians at a meeting
the non-selective herbicide, paraquat, of its FIFRA Scientific Advisory Panel in
in Annex I of the EU agrochemical October. The meeting will consider the
registration Directive (91/414) with Agency’s assessment of Syngenta’s
immediate effect. The Court concluded studies on the effects of atrazine on
that the Commission’s decision to amphibian gonadal development, which
re-register the ai “fails to satisfy the were conducted in 2005-06.
requirement of protection of human and
animal health”. n US and Canadian grower groups have
drawn up a priority list of pesticides
n EU approvals are to be withdrawn and commodities with differences in
for just over 100 active ingredients maximum residue limits in the two
due to lack of support for their countries. The NAFTA Technical Working
evaluation in the fourth round of the Group on Pesticides will now analyse the
EU review of existing ais. There were database and identify mechanisms for
originally around 270 ais in the fourth addressing the growers’ priorities.
round, which includes plant extracts,
pheromones, micro-organisms, n Canadian federal and provincial
rodenticides and fumigants. pesticide regulatory officials have
proposed the establishment of two
n The European Crop Protection classes of home and garden pesticides
Association (ECPA) has expressed based on potential risks to users and
concern over MEPs’ efforts to the environment. The current domestic
introduce stricter legislation as part class of pesticides would be subdivided
of the forthcoming revision of the EU into “self-select” and “controlled
agrochemical registration Directive purchase” products.
6 September 2007 • www.agrow.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82